Magnair, an eFlow closed system nebulizer, together with Sunovion’s Lonhala is the first eFlow technology-based product to receive FDA approval to treat chronic obstructive pulmonary disease (COPD). Pari Pharma GmbH, a company focused on the development and commercialization of advanced aerosol delivery systems based on eFlow technology, announced approval of its first eFlow closed system…